Katherine Stueland Sema4 Holdings Corp. (SMFR) insider trading activity

Katherine Stueland is Chief Executive Officer of Sema4 Holdings Corp.. Currently has a direct ownership of 1,720 shares of SMFR, which is worth approximately $584. The most recent transaction as insider was on Jul 09, 2025, when has been sold 3,220 shares (Class A Common Stock) at a price of $93.0 per share, resulting in proceeds of $299,460. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.72K

0% 3M change

98.11% 12M change

Total Value Held $584

Katherine Stueland Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 09 2025	SELL Open market or private sale	$299,460 $93.0 p/Share	3,220 Reduced 65.18%	1,720 Class A Common Stock
Jul 01 2025	SELL Open market or private sale	$884,194 $91.56 p/Share	9,657 Reduced 66.16%	4,940 Class A Common Stock
Jun 16 2025	SELL Open market or private sale	$680,149 $64.77 p/Share	10,501 Reduced 41.84%	14,597 Class A Common Stock
Jun 16 2025	BUY Exercise of conversion of derivative security	-	18,750 Added 42.76%	25,098 Class A Common Stock
Jun 09 2025	SELL Open market or private sale	$264,009 $72.55 p/Share	3,639 Reduced 36.44%	6,348 Class A Common Stock
Jun 09 2025	BUY Exercise of conversion of derivative security	-	6,547 Added 39.6%	9,987 Class A Common Stock
Apr 29 2025	SELL Open market or private sale	$243,595 $113.09 p/Share	2,154 Reduced 38.51%	3,440 Class A Common Stock
Apr 29 2025	BUY Exercise of conversion of derivative security	-	3,874 Added 40.92%	5,594 Class A Common Stock
Apr 09 2025	SELL Open market or private sale	$4,162,242 $89.33 p/Share	46,594 Reduced 96.44%	1,720 Class A Common Stock
Mar 26 2025	SELL Open market or private sale	$4,427,931 $95.12 p/Share	46,551 Reduced 49.07%	48,314 Class A Common Stock
Mar 26 2025	BUY Exercise of conversion of derivative security	-	80,000 Added 45.75%	94,865 Class A Common Stock
Mar 17 2025	SELL Open market or private sale	$1,021,160 $96.71 p/Share	10,559 Reduced 41.53%	14,865 Class A Common Stock
Mar 16 2025	BUY Exercise of conversion of derivative security	-	18,750 Added 42.45%	25,424 Class A Common Stock
Mar 13 2025	SELL Open market or private sale	$96,416 $89.44 p/Share	1,078 Reduced 13.91%	6,674 Class A Common Stock
Mar 10 2025	SELL Open market or private sale	$258,707 $94.73 p/Share	2,731 Reduced 26.05%	7,752 Class A Common Stock
Mar 09 2025	BUY Exercise of conversion of derivative security	-	6,546 Added 38.44%	10,483 Class A Common Stock
Jan 29 2025	SELL Open market or private sale	$130,041 $78.48 p/Share	1,657 Reduced 29.62%	3,937 Class A Common Stock
Jan 29 2025	BUY Exercise of conversion of derivative security	-	3,874 Added 40.92%	5,594 Class A Common Stock
Jan 07 2025	SELL Open market or private sale	$4,879,243 $94.89 p/Share	51,420 Reduced 96.76%	1,720 Class A Common Stock
Jan 02 2025	SELL Open market or private sale	$1,406,268 $78.1 p/Share	18,006 Reduced 25.31%	53,140 Class A Common Stock
Dec 16 2024	SELL Open market or private sale	$805,951 $76.75 p/Share	10,501 Reduced 12.86%	71,146 Class A Common Stock
Dec 16 2024	BUY Exercise of conversion of derivative security	-	18,750 Added 18.68%	81,647 Class A Common Stock
Dec 09 2024	SELL Open market or private sale	$279,590 $76.37 p/Share	3,661 Reduced 5.5%	62,897 Class A Common Stock
Dec 09 2024	BUY Exercise of conversion of derivative security	-	6,547 Added 8.96%	66,558 Class A Common Stock
Nov 18 2024	SELL Open market or private sale	$1,548,105 $69.4 p/Share	22,307 Reduced 27.1%	60,011 Class A Common Stock

Also insider at

NVTA

Invitae Corp Healthcare

Chief Commercial Officer